Agenus Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AGEN Nasdaq 2830 www.agenusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agenus Inc.

Agenus Says BOT/BAL Combination Shows 42% Survival Rate in Microsatellite-Stable Metastatic Colorectal Cancer - Jul 7th, 2025 9:20 am
Biogen Begins Phase III Felzartamab Study for Third Kidney Disease - Jul 1st, 2025 8:50 am
Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag - Jun 25th, 2025 8:02 am
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer - Jun 24th, 2025 7:04 am
After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright - Jun 19th, 2025 7:55 am
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology - Jun 17th, 2025 5:30 am
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - Jun 16th, 2025 1:01 pm
SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion - Jun 16th, 2025 6:45 am
Agenus Announces Virtual Annual Shareholders Meeting - Jun 10th, 2025 11:30 am
Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Jun 4th, 2025 7:55 am
Agenus and Zydus sign agreements for botensilimab and balstilimab - Jun 4th, 2025 5:33 am
Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences - Jun 3rd, 2025 9:23 am
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - Jun 3rd, 2025 5:00 am
Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer - May 30th, 2025 5:30 am
Despite Fast-paced Momentum, Agenus (AGEN) Is Still a Bargain Stock - May 19th, 2025 6:50 am
Agenus says expanded MSS mCRC cohort data to be presented at ESMO GI - May 16th, 2025 8:45 am
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025 - May 15th, 2025 8:40 am
Agenus Inc (AGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - May 13th, 2025 1:03 am
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2025 6:50 am
Agenus: Q1 Earnings Snapshot - May 12th, 2025 5:47 am